Background
Acetylcholinesterase (AChE; EC 3.1.1.7) is one of the most efficient biological catalysts known and plays a key role in cholinergic neurotransmission by hydrolysing the transmitter acetylcholine (ACh), so terminating its action. However, a growing body of evidence suggests that AChE has additional functions that are unrelated to cholinergic transmission.
The first indication that AChE may possess functions other than hydrolysis of ACh was the observation that AChE is not confined to tissues which participate in cholinergic transmission. In certain brain regions, there are high levels of AChE, while the levels of a more reliable marker of cholinergic transmission, choline acetyltransferase (ChAT), and of ACh itself, are extremely low in comparison and there are few cholinergic synapses This disparity in the distribution of AChE and other cholinergic markers is also apparent during the development of the nervous system. Many immature non-cholinergic neurons transiently express high levels of AChE in the absence of Abbreviations used: ACh, acetylcholine; AChE, acetylcholinesterase; BuChE, butyrylcholine esterase; ChAT, choline acetyltransferase.
ChAT or ACh, and with no apparent cholinergic input [4] . In a wide range of tissues and species the transient appearance of AChE seems to coincide with the period of time in which the cells are extending neurites into their target areas [4-71. In cultures of chick tectal neurons, neurite elongation is decreased in the presence of some but not all cholinesterase inhibitors, despite efficient blockade of AChE activity [8] . Such 
Soluble and secreted AChE
The classical view of AChE is of a membranebound protein; indeed, AChE has often been used as a marker for neuronal membranes in subcellular fractionation procedures. However, many tissues, including brain and muscle, contain a significant proportion of AChE species that are soluble in lowsalt solutions and which lack a hydrophobic domain [9] . Examination of the amino acid sequences derived from AChE genes show that AChE has the features of a secreted rather than a transmembrane protein since it lacks long hydrophobic stretches, other than that which forms the signal peptide [12] . [21] , substantia nigra 1221 and striatum [23] . Such a phenomenon explains the presence of soluble AChE isoforms in mammalian cerebrospinal fluid [24] .
The secretion of AChE from the brain appears to be a well-regulated &'+-dependent process which is under the control of various physiological stimuli. Studies using push-pull cannulae implanted within the hippocampus have shown that local secretion of AChE is greatly enhanced by activation of local muscarinic cholinergic receptors and depressed by y-aminobutyric acid agonists [ 181. Hippocampal secretion of AChE is also evoked by high-frequency action potentials in the septohippocampal pathway [20] (see Figure 1 ). Lesion studies indicate that the terminals of this pathway are probably the origin of the secreted AChE within the hippocampus [19] . It is therefore possible that this secreted AChE has a function in terminating cholinergic transmission, thus complementing the action of membrane-bound AChE at the cholinergic synapses.
In other regions of the brain, however, evidence suggests that secretion of AChE is unrelated to cholinergic transmission. In the substantia nigra secretion of AChE is from non-cholinergic, dopa- minergic cells since it is abolished by 6-hydroxydopamine lesions [2] . In contrast to the hippocampus, this secretion is not controlled by the firing rate of these cells, since dopaminergic drugs and 5-hydroxytryptamine affect the secretion of AChE in a manner unrelated to their effect on the cells' firing rate [22] , a phenomenon which may be related to the dendritic origin of secreted AChE in the nigra. Nigral cells do receive a sparse cholinergic innervation, but this appears to have little effect on nigral secretion of AChE since this is unaffected by local application of various cholinergic agonists 1251. It is therefore unlikely that secreted AChE plays a role in cholinergic transmission in the nigra.
Similarly, in the cerebellar cortex, it is extremely difficult, if not impossible, to ascribe a cholinergic function to secreted AChE. In this region of the brain there is a marked discrepancy in the levels of AChE and ChAT or ACh and, in spite of extremely high levels of AChE, there is no con- ] or by systemic administration of harmaline which stimulates the climbing fibres [21] . Local infusion of the cholinergic agonist carbachol has no effect on AChE secretion.
Recent studies in the substantia nigra using a highly sensitive 'on-line' chemiluminescent assay for AChE activity, which allows levels of AChE in push-pull perfusates to be monitored on a much smaller time sale, have demonstrated that secretion of AChE is closely linked to physiological events. In the awake animal nigral secretion of AChE is pulsatile in nature [ 281, and is frequently, but not invariably, associated with periods of locomotion 128,291.
Nigral secretion of AChE is also enhanced by activation of visual sensory inputs with light flashes [.lo]> which suggests that it may play a role in visuo-motor interactions.
It should be pointed out that this phenomenon of secretion of AChE is certainly not unique among mammalian neuronal proteins. Indeed, the secretion of specific proteins from nervous tissue during the process of depolarization was first established by experiments demonstrating the secretion of chromogranin-A by the chromaffin cells of the list of secreted neuronal proteins has been extended to include dopamine-/3-hydroxylase 1321, aminopeptidase [ 331, proteases 1341, and of course AChE itself In the majority of cases, however, the functions of these secreted forms remain as yet unknown. adrenal medulla [ 3 11. Since this demonstration, the 7'5 I
Modulation of neuronal activity by AChE
The widespread phenomenon of secretion of AChE in response to physiologically relevant stimuli is certainly suggestive of additional non-cholinergic roles for AChE in the extracellular space, particularly as it is often divorced from cholinergic transmission. The earliest evidence for such a non-classical role of AChE protein comes from the studies of Greenfield and colleagues (for a review, see [22] ) which demonstrated that microinfusion of purified AChE into the nigra in sztu produced marked behavioural effects such as turning behaviour, stereo-' typy, and chewing movements [30] . Such treatment also depressed the firing of nigral cells [Z] . Over the past five years these modulatory actions of AChE on neuronal behaviour have been confirmed at the cellular level by intracellular recording studies in guinea pig brain slices from a wide range of brain regions (see Table 1 for summary). In the substantia nigra, both bath application and the pressure ejection of AChE in the region of the dendrites produces a reversible hyperpolarization of cells which is accompanied by a fall in input resistance [22] . These effects of AChE are probably due to the opening of K + channels (of the ATPsensitive type) since they had a reversal potential near the K + equilibrium potential, they were unaffected by blockade of Na+ or Ca" channels, they were blocked by the sulphonylurea tolbutamide, and they were enhanced in the presence of low glucose concentrations when levels of ATP would be limiting [35] . Although these neurons do receive a sparse cholinergic projection, the observed effects of AChE cannot be due to termination of cholinergic transmission since they were not blocked by pretreatment of the AChE with the irreversible organophosphate inhibitor Soman, nor were they mimicked by butyrylcholinesterase (HuChE; EC 3.1.1.8), although this protein can also hydrolyse ACh [ 3.51.
The view of AChE as a modulator of neuronal behaviour unrelated to its ability to hydrolyse ACh is also supported by the results of Appleyard and Jahnsen [ 361 which were obtained using intracellular recordings of Purkinje cells in slices of cerebellar cortex (see Figure 2) . In this case, however, a different mechanism appears to be involved. Application of AChE (20 pg/ml) to the bath medium was found to enhance the synaptic responses evoked by stimulation of the climbing fibres; in particular, there was a marked enhancement of a late plateau-like portion of the response, which was often sufficiently elevated to initiate action potentials in the presence of AChE "1. The transmitter released by climbing fibres is probably an excitatory amino acid; application of AChE also enhanced the response of these cells to iontophoretic applications of aspartate or glutamate, such that they became larger and faster. These particular modulatory effects of AChE may be due to a blockade of excitatory amino acid uptake, leading to enhanced levels of the released transmitter, since they are prevented by the reuptake of blockers ui,-Z-arnino-4-phosphonobutyric acid and hydrokainate.
In contrast to the situation in the nigra, AChE does not appear to promote opening of K + channels in the cerebellum since it did not produce any significant change in membrane potential or input resistance. However, AChE does appear to modulate another membrane conductance in Purkinje cells: it reduces or delays a non-activating Na+ current which contributes to the plateau potentials observed in these cells and in turn leads to activation of high-threshold Ca2+ spikes 136). The net result is a change in the firing pattern of the cells, in favour of simple Na+ spike firing. As in the nigra, none of these effects of AChE on Purkinje cells can be attributed to hydrolysis of ACh since there is no evidence for cholinergic transmission in the cerebellar cortex in the first place, the effects cannot be blocked by the irreversible cholinergic inhibitor Soman, and they cannot be mimicked by HuChE Similar modulatory actions of AChE are also observed in a region of the brain where its presence, and its secretion, is associated with cholinergic transmission, i.e. the hippocampus. As in the cerebellum, AChE appears to enhance synaptic responses produced by excitatory amino acids since it produces a long-lasting potentiation of the extracellularly recorded population spike that is evoked in the CAI region of the pyramidal cell layer of the hippocampus by stimulation of the Schaffer collaterals (M. Appleyard, unpublished work). AChE also produces modulation of a membrane conductance in pyramidal cells: intracellular recording studies have shown that AChE produces membrane hyperpolarization, probably by opening K + channels [37] . The type of K + channel involved has yet to be determined. Although the hippocampus is undoubtedly a cholinergic region, these effects of AChE still cannot be attributed to an effect on cholinergic transmission since they both persisted in the presence of the cholinergic antagonist atropine and they could not be reproduced by HuChE [37] (M. Appleyard, unpublished work).
There have been reports that purified preparations of AChE exhibit tryptic-like protease activity which was once claimed to be intrinsic to AChE [38] but now looks like a contaminant that can be removed . This does, of course, raise the question of whether the modulatory effects of AChE described above can be attributed to protease action. It would seem to be unlikely since (a) highly purified AChE from electric eel was more effective on nigral cells than crude preparations, (b) the effects of AChE on both nigral and cerebellar cells persisted after treatment with Soman, which will inhibit serine proteases such as trypsin, and (c) in the hippocampus [37] and in the cerebellum (M. mechanism. This is probably not the case since a Purified AChE from a number of different similar aryl acylamidase activity is also present in sources has also been shown to exhibit aryl acylpurified serum cholinesterase, i.e. BuChE [44] , yet amidase activity [42, 43] , so we should also consider application of BuChE failed to mimic the effects of the possibility that the actions of AChE described AChE. The novel effects of AChE described in this article must therefore be due to some other, as yet undetermined, property of AChE. It may seem odd that a protein with such a well-designed enzymic activity as that displayed by AChE should also possess another function which is probably mediated by a different site on the molecule. However, it should be remembered that there are precedents for such a situation, probably the most well-known of which is the exonuclease activity exhibited by many DNA polymerases [45] .
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Structure, Mechanism and Inhibition of Neuroactive Enzymes
For example a 3'4' exonuclease activity has been found in the catalytic polypeptide of Drosophila polymerase a even when it has been isolated from the other subunits. It may also seem strange that a large protein should be secreted into the extracellular space from one cell in order to exert modulatory effects on other cells, but again there are wellknown precedents in the form of glycoprotein hormones such as gonadotropins, and protein hormones such as insulin and growth hormone which exert some of their effects on cell-surface receptors, and growth factors such as nerve growth factor which undergo endocytosis. Admittedly, these do have lower molecular masses than the G, form of AChE secreted from cells, but their existence means that we cannot discount a similar cell-surface receptor interaction mechanism for the non-classical actions of AChE on neuronal behaviour.
Inhibitors of AChE and their modulatory actions
The classical catalytic activity of AChE can be inhibited by a broad range of chemicals which can be roughly divided into three groups: those which interact with the active site of the enzyme, those which interact with a peripheral anionic or allosteric site and probably induce a conformational change, and those which interact with both sites. Any of these compounds could have the potential to disrupt the non-classical actions of AChE described above.
As we have already seen, however, agents such as Soman, which interact irreversibly with the active site alone, do not prevent the modulatory actions of AChE on neuronal behaviour. However, it is possible that such actions of AChE could be disrupted by inhibitors that bind to the peripheral site. Although this has yet to be tested directly, there is some circumstantial evidence to support such a supposition. Fasciculins are naturally occurring peptide inhibitors of AChE found in mamba snake venoms which bind to a peripheral site on the protein distinct from the catalytic site [46] . Microinfusion of fasciculin into the rat substantia nigra results in marked inhibition (87%) of nigral AChE activity and induces modest contraversive turning behaviour which could not be completely abolished by the muscarinic cholinergic antagonist atropine [47] . Similarly, microinfusion of fasciculin into the locus coeruleus, another brain region where AChE is present in non-cholinergic neurons [2], induced a significant increase in noradrenaline levels which could not be blocked by atropine [48] . While a nicotinic involvement has not yet been ruled out, it is certainly tempting to attribute these effects of fasciculin to a disruption of the modulatory actions of AChE.
Recent studies on developing chick neurons also suggest that binding of inhibitors to a peripheral site on AChE can disrupt neurite outgrowth, while binding to the active site alone is without effect. Addition of HW 284c5 1, which interacts with both the active and peripheral sites, to tectal cell cultures strongly decreased neurite outgrowth in a dose-dependent manner, while echothiophate, which only binds to the active site, had no effect [8].
From this discussion it is clear that the effects, on the modulatory actions of AChE, of a wide range of AChE inhibitors acting at different sites merit future study. Identification of agents that could disrupt or augment such functions could have important implications for the treatment of central nervous system diseases. 
